Validation study of the Parkinson’s Fatigue Scale in advanced Parkinson’s disease

References

• Lewis G, Wessely S. The epidemiology of fatigue: more questions than answers. J Epidemiol Community Health. 1992;46(2):92–97.1583440
   PubMed Web of Science ®Google Scholar
• Kant IJ, Bültmann U, Schröer KA, Beurskens AJ, Van Amelsvoort LG, Swaen GM. An epidemiological approach to study fatigue in the working population: the Maastricht Cohort Study. Occup Environ Med. 2003;60(Suppl 1):i32–i39.12782745
   PubMedGoogle Scholar
• Stadje R, Dornieden K, Baum E, et al. The differential diagnosis of tiredness: a systematic review. BMC Fam Pract. 2016;17(1):147. doi:10.1186/s12875-016-0545-527765009
   PubMed Web of Science ®Google Scholar
• Karlsen K, Larsen JP, Tandberg E, Jørgensen K. Fatigue in patients with Parkinson’s disease. Mov Disord. 1999;14(2):237–241.10091615
   PubMed Web of Science ®Google Scholar
• Friedman JH, Friedman H. Fatigue in Parkinson’s disease: a nine‐year follow‐up. Mov Disord. 2001;16(6):1120–1122.11748745
   PubMed Web of Science ®Google Scholar
• Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord. 2001;16(3):507–510.11391746
   PubMed Web of Science ®Google Scholar
• Herlofson K, Kluger BM. Fatigue in Parkinson’s disease. J Neurol Sci. 2017;374:38–41. doi:10.1016/j.jns.2016.12.06128087059
   PubMed Web of Science ®Google Scholar
• Kluger BM, Herlofson K, Chou KL, et al. Parkinson’s disease-related fatigue: a case definition and recommendations for clinical research. Mov Disord. 2016;31(5):625–631. doi:10.1002/mds.2651126879133
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.
   Google Scholar
• Grace J, Mendelsohn A, Friedman JH. A comparison of fatigue measures in Parkinson’s disease. Parkinsonism Relat Disord. 2007;13(7):443–445. doi:10.1016/j.parkreldis.2006.09.00117055331
   PubMed Web of Science ®Google Scholar
• Rochester L, Hetherington V, Jones D, et al. Attending to the task: interference effects of functional tasks on walking in Parkinson’s disease and the roles of cognition, depression, fatigue, and balance. Arch Phys Med Rehabil. 2004;85(10):1578–1585.15468014
   PubMed Web of Science ®Google Scholar
• Hagell P, Brundin L. Towards an understanding of fatigue in Parkinson disease. J Neurol Neurosurg Psychiatry. 2009;80(5):489–492. doi:10.1136/jnnp.2008.15977219204024
   PubMed Web of Science ®Google Scholar
• Martinez‐Martin P, Rodriguez‐Blazquez C, Kurtis MM, Chaudhuri K. The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson’s disease. Mov Disord. 2011;26(3):399–406. doi:10.1002/mds.2346221264941
   PubMed Web of Science ®Google Scholar
• Dogan VB, Koksal A, Dirican A, Baybas S, Dirican A, Dogan GB. Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson’s disease. Neurol Sci. 2015;36(12):2221–2226. doi:10.1007/s10072-015-2340-926198763
   PubMed Web of Science ®Google Scholar
• Lou JS, Kearns G, Benice T, Oken B, Sexton G, Nutt J. Levodopa improves physical fatigue in Parkinson’s disease: a double‐blind, placebo‐controlled, crossover study. Mov Disord. 2003;18(10):1108–1114. doi:10.1002/mds.1050514534913
   PubMed Web of Science ®Google Scholar
• Pavese N, Metta V, Bose SK, Chaudhuri KR, Brooks DJ. Fatigue in Parkinson’s disease is linked to striatal and limbic serotonergic dysfunction. Brain. 2010;133(11):3434–3443. doi:10.1093/brain/awq26820884645
   PubMed Web of Science ®Google Scholar
• Friedman JH, Brown RG, Comella C, et al. Fatigue in Parkinson’s disease: a review. Mov Disord. 2007;22(3):297–308. doi:10.1002/mds.2124017133511
   PubMed Web of Science ®Google Scholar
• Brown RG, Dittner A, Findley L, Wessely SC. The Parkinson fatigue scale. Parkinsonism Relat Disord. 2005;11(1):49–55. doi:10.1016/j.parkreldis.2004.07.00715619463
   PubMed Web of Science ®Google Scholar
• Kummer A, Scalzo P, Cardoso F, Teixeira AL. Evaluation of fatigue in Parkinson’s disease using the Brazilian version of Parkinson’s Fatigue Scale. Acta Neurol Scand. 2011;123(2):130–136. doi:10.1111/j.1600-0404.2010.01364.x20456242
   PubMed Web of Science ®Google Scholar
• Hagell P, Rosblom T, Pålhagen S. A Swedish version of the 16‐item Parkinson Fatigue Scale (PFS‐16). Acta Neurol Scand. 2012;125(4):288–292. doi:10.1111/j.1600-0404.2011.01560.x21692754
   PubMed Web of Science ®Google Scholar
• Fu R, Cui SS, Du JJ, et al. Validation of the Parkinson Fatigue Scale in Chinese Parkinson’s disease patients. Brain Behav. 2017;7(6):e00712. doi:10.1002/brb3.71228638717
   PubMed Web of Science ®Google Scholar
• Ozturk EA, Kocer BG, Umay E, Cakci A. Cross-cultural adaptation and psychometric evaluations of the Turkish version of Parkinson Fatigue Scale. Qual Life Res. 2018;27(10):2719–2730. doi:10.1007/s11136-018-1907-329881896
   PubMed Web of Science ®Google Scholar
• Çilga G, Genç A, Çolakoğlu BD, Kahraman T. Turkish adaptation of Parkinson fatigue scale and investigating its psychometric properties. Int J Rehabil Res. 2019;42(1):20–25. doi:10.1097/MRR.0000000000000314
   Web of Science ®Google Scholar
• Dagklis IE, Tsantaki E, Kazis D, et al. The Parkinson fatigue scale: an evaluation of its validity and reliability in Greek Parkinson’s disease patients. Neurol Sci. 2019. doi:10.1007/s10072-018-3695-5
   Web of Science ®Google Scholar
• Friedman JH, Alves G, Hagell P, et al. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson’s disease. Mov Disord. 2010;25(7):805–822. doi:10.1002/mds.2298920461797
   PubMed Web of Science ®Google Scholar
• Valldeoriola F, Catalab MJ, Escamilla-Sevilla F, et al. Study on patient‐ and caregiver‐reported symptoms and outcomes with levodopa‐carbidopa intestinal gel for the treatment of advanced Parkinson’s Disease. ADEQUA Study. Mov Disord. 2018;33(Suppl 2):S120.
   Google Scholar
• Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007;22(16):2314–2324. doi:10.1002/mds.2184418098298
   PubMed Web of Science ®Google Scholar
• Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi:10.1016/j.jclinepi.2006.03.01217161752
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, Kurtis MM, Skorvanek M. Measurement of nonmotor symptoms in clinical practice. Intern Rev Neurobiol. 2017;133:291–345.
   PubMed Web of Science ®Google Scholar
• Nilsson MH, Bladh S, Hagell P. Fatigue in Parkinson’s disease: measurement properties of a generic and a condition-specific rating scale. J Pain Symptom Manage. 2013;46(5):737–746. doi:10.1016/j.jpainsymman.2012.11.00423507131
   PubMed Web of Science ®Google Scholar
• Fahn S, Elton RL. Members of the UPDRS Development Committee. Unified Parkinson’s Disease Rating Scale In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent Developments in Parkinson’s Disease. Vol. 2 Florham Park: Macmillan Healthcare Information; 1987:153–164.
   Google Scholar
• Schwab J, England A. Projection technique for evaluating surgery in Parkinson’s disease In: Gillingham F, Donaldson M, editors. Third Symposium on Parkinson’s Disease. Vol. 232 Edinburgh: Livingston; 1969:152–157.
   Google Scholar
• Shulman LM, Armstrong M, Ellis T, et al. Disability rating scales in Parkinson’s disease: critique and recommendations. Mov Disord. 2016;31(10):1455–1465. doi:10.1002/mds.2664927193358
   PubMed Web of Science ®Google Scholar
• Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–442.6067254
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Martinez‐Martin P, Brown RG, et al. The metric properties of a novel non‐motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord. 2007;22(13):1901–1911. doi:10.1002/mds.2159617674410
   PubMed Web of Science ®Google Scholar
• Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28–37.
   PubMedGoogle Scholar
• Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–897.3204199
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
   Google Scholar
• Starkstein SE, Mayberg HS, Preziosi T, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci. 1992;4(2):134–139. doi:10.1176/jnp.4.2.1341627973
   PubMed Web of Science ®Google Scholar
• Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res. 1995;4(3):241–248.7613534
   PubMed Web of Science ®Google Scholar
• Zarit SH, Orr NK, Zarit JM. The Hidden Victims of Alzheimer’s Disease: Families under Stress. New York: New York University Press; 1985.
   Google Scholar
• Martínez-Martín P, Forjaz MJ, Frades-Payo B, et al. Caregiver burden in Parkinson’s disease. Mov Disord. 2007;22(7):924–931. doi:10.1002/mds.2135517238193
   PubMed Web of Science ®Google Scholar
• Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord. 2010;25(15):2649–2653. doi:10.1002/mds.2342921069833
   PubMed Web of Science ®Google Scholar
• Smith SC, Lamping DL, Banarjee S, et al. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess. 2005;9(10):16–19. doi:10.3310/hta9100
   Web of Science ®Google Scholar
• Martinez-Martin P, Rodriguez-Blazquez C, Abe K, et al. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology. 2009;73(19):1584–1591. doi:10.1212/WNL.0b013e3181c0d41619901251
   PubMed Web of Science ®Google Scholar
• McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4(4):293–307. doi:10.1007/BF015938827550178
   PubMed Web of Science ®Google Scholar
• Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess. 2004;8(9):7–10. doi:10.3310/hta8090
   Web of Science ®Google Scholar
• Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11(3):193–205. doi:10.1023/A:101529102131212074258
   PubMed Web of Science ®Google Scholar
• Clark LA, Watson D. Constructing validity: basic issues in objective scale development. Psychol Assessm. 1995;7:309–319. doi:10.1037/1040-3590.7.3.309
   Web of Science ®Google Scholar
• Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ. A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry. 2005;76(1):58–63. doi:10.1136/jnnp.2003.01789715607996
   PubMed Web of Science ®Google Scholar
• Fayers PM, Machin D. Quality of Life: Assessment, Analysis and Interpretation. New Jersey: John Wiley & Sons; 2000:72–90.
   Google Scholar
• Fitzpatrick R, Norquist JM, Jenkinson C. Distribution-based criteria for change in health-related quality of life in Parkinson’s disease. J Clin Epidemiol. 2004;57(1):40–44. doi:10.1016/j.jclinepi.2003.07.00315019009
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York: Psychology Press; 1988.
   Google Scholar
• Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003;56(5):395–407.12812812
   PubMed Web of Science ®Google Scholar
• Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539–549. doi:10.1007/s11136-010-9606-820169472
   PubMed Web of Science ®Google Scholar
• Mokkink LB, Terwee CB, Knol DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010;10:22. doi:10.1186/1471-2288-10-2220298572
   PubMed Web of Science ®Google Scholar
• Miwa H, Miwa T. Fatigue in patients with Parkinson’s disease: impact on quality of life. Intern Med. 2011;50(15):1553–1558.21804280
   PubMed Web of Science ®Google Scholar
• Sáez-Francàs N, Hernández-Vara J, Corominas Roso M, Alegre Martín J, Casas Brugué M. The association of apathy with central fatigue perception in patients with Parkinson’s disease. Behav Neurosci. 2013;127(2):237–244. doi:10.1037/a003153123339489
   PubMed Web of Science ®Google Scholar
• Nodel M, Yakhno N, Medvedeva A, Kulikov M. Apathy in Parkinson’s disease. Front Biol. 2014;9(4):324–331. doi:10.1007/s11515-014-1322-2
   Google Scholar
• Cochrane GD, Rizvi S, Abrantes AM, Crabtree B, Cahill J, Friedman JH. The association between fatigue and apathy in patients with either Parkinson’s disease or multiple sclerosis. Parkinsonism Relat Disord. 2015;21(9):1093–1095. doi:10.1016/j.parkreldis.2015.07.00726228083
   PubMed Web of Science ®Google Scholar
• Siciliano M, Trojano L, De Micco R, et al. Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients. Parkinsonism Relat Disord. 2017;45:63–68. doi:10.1016/j.parkreldis.2017.10.00429037500
   PubMed Web of Science ®Google Scholar
• Ongre SO, Larsen JP, Tysnes OB, Herlofson K. Fatigue in early Parkinson’s disease: the Norwegian ParkWest study. Eur J Neurol. 2017;24(1):105–111. doi:10.1111/ene.1316127670392
   PubMed Web of Science ®Google Scholar
• Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson’s disease. Mov Disord. 2009;24(15):2175–2186. doi:10.1002/mds.2258919768724
   PubMed Web of Science ®Google Scholar
• Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson’s disease? J Neurol, Neurosurg Psychiatry. 2000;69(3):308–312. doi:10.1136/jnnp.69.3.30810945804
   PubMed Web of Science ®Google Scholar
• Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord. 2009;24(11):1641–1649. doi:10.1002/mds.2264319514014
   PubMed Web of Science ®Google Scholar
• Okuma Y, Kamei S, Morita A, et al. Fatigue in Japanese patients with Parkinson’s disease: a study using Parkinson fatigue scale. Mov Disord. 2009;24(13):1977–1983. doi:10.1002/mds.2273119672993
   PubMed Web of Science ®Google Scholar
• Stocchi F, Abbruzzese G, Ceravolo R, et al. Prevalence of fatigue in Parkinson disease and its clinical correlates. Neurology. 2014;83(3):215–220. doi:10.1212/WNL.000000000000058724928125
   PubMed Web of Science ®Google Scholar